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1. Introduction
Reflection on mast cells allows us to understand that 
the human and natural environment is subject to constant 
adaptation and there is a fine-tuned balance established 
with careful selection of the fittest throughout evolution. 
The message from looking at mast cells must trigger a 
warning signal in judging our choices, because harefooted, 
rough disturbances to the delicate balance of homeostatic 
organization may have far-reaching, irreversible 
consequences. Due to the genuine qualities of mast cells, 
therapeutic interventions may not always be feasible, 
it appears to be prudent to concentrate our efforts at 
preventing harsh perturbations into our balance, because 
during quick-fired changes, time for adaptation is not 
allowed, and selection of the fittest may be outweighed by 
shifting the phenotype towards disease and degeneration. 
This review is a recollection to emphasize how 
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During the past decades, populous expansion in mast cell scientific 
literature came forth with more, than forty-four thousand PubMed 
publications available to date. Such surge is due to the appreciation 
of the momentous role of mast cells in the evolution of species, in the 
development and maintenance of vital physiological functions, such as 
reproduction, homeostasis, and fluids, diverse immunological roles, and 
the potential of far-reaching effects despite minute numbers. While the 
emerging knowledge of the importance of mast cells in equilibrium comes 
of age when looking at the matter from an evolutionary perspective, the 
recognition of mast cells beyond detrimental performance in allergies 
and asthma, during protection against parasites, falters. Beyond well-
known classical functions, mast cells can process and present antigens, 
can serve as a viral reservoir, can respond to hormones and xenobiotics, 
initiate antiviral and antibacterial responses, phagocytosis, apoptosis, and 
participate in important developmental cornerstones. During evolution, 
upon the development of a sophisticated niche of innate and adaptive cell 
populations, certain mast cell functions became partially transmutable, 
yet the potency of mast cells remained considerable. Reviewing mast 
cells enables us to reflect on the certitude, that our sophisticated, complex 
physiology is rooted deeply in evolution, which we carry ancient 
remnants of, ones that may have decisive roles in our functioning. This 
communication sets out the goal of characterizing mast cells, particularly 
the aspects less in limelight yet of immense significance, without the 
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pathophysiological happenings are interconnected, how 
external influences are widespread, and how obsolete it is 
to analyze and conclude from a narrow-angle. The second 
major objective is to direct the attention of healthcare 
professionals towards unsettling matters of contention, 
the process of understanding from a research perspective. 
There is an increasing price for the comforts of modern 
lifestyle, which is often driven by a material growth-
oriented attitude, inconsiderate demand, producing excess 
waste, spreading all over the world.
Overall features
Phylogenetically at the beginning of the emergence 
of vertebrates, mast cells (MCs) were the primordial 
immune cells, carrying out the majority of self-defensive 
functions [1]. Their appearance reaches back to invertebrae 
chordae, two hundred million years before the emergence 
of immunoglobulins, when mast cells served wide 
housekeeping functions, beyond immunological ones. 
MCs are pleiotropic and plastic, even today in highly 
sophisticated and specialized organisms. MCs are well 
fed as their name implies, filled with preformed forcible 
mediators with the proficiency of very early release 
upon stimulation, powerful, multifarious, and long-
reaching effects. The diverse nature of granule content 
reflects their primordial origin. It is heparin, histamine, 
proteases, (such as tryptase, carboxypeptidase, and 
chymase), TNFα, prostaglandins, leukotrienes, and many 
more. MCs are customarily categorized based on their 
granule content tryptase and chymase, their strategical 
location on interfaces between host and environment, 
tissue and vessels to mucosal and connective tissue mast 
cells [2]. Despite their rarity, the effector potency can be 
immense, best demonstrated by the abrupt, profound, 
life-threatening anaphylactic reactions, elicited by 
disproportionally small stimuli in susceptible individuals. 
Intensivists, who appreciate the crucial notion of early 
effective interventions in facing forceful noxious stimuli 
severely compromising organ functions, may turn their 
eyes towards the early and persuasively reacting mast 
cells. 
2. Origin, Ligands, Signaling Pathways
The fundamental cradle of immature mast cells is 
the bone marrow. They are derived from pluripotent 
hematopoietic progenitors. The main driver of mast 
development is SCF (stem cell factor), eliciting its 
effect upon binding to the ckit receptor (CD117) [3]. 
SCF is a growth factor produced by endothelial cells 
and fibroblasts, present in membrane-bound and soluble 
forms, leading to proliferation and differentiation of 
hematopoietic cells, melanocytes, and germ cells, 
inhibiting their apoptosis. Mast cells are derived from the 
bone marrow CD13+, CD34+, CD117+ progenitors, upon 
egress circulate in the blood as immature progenitors. 
When homed, complete their development in a cytokine 
environment of the target tissue to achieve mature 
phenotype. Mast cells are abundant in tissues with 
proximity to the external environment. SCF is upregulated 
by hypoxia-inducible factor1-alpha (HIF-1α), epidermal 
growth factor, ultraviolet B light, for example.
SCF binds to ckit (CD117), a type III tyrosine kinase 
receptor, which is present on early hematopoietic cells, 
later ckit expression is lost, except mainly on mast 
cells, which express high levels and depend on ckit for 
their survival, proliferation, homing, and function, such 
as degranulation and cytokine production. Upon ckit 
dimerization or oligomerization, the downstream PI3K-
Akt prosurvival pathway is activated. CD117 is also 
present on melanocytes, germs cells, interstitial cells 
of Cajal, eosinophils, NK cells. Dendritic cell (DC) 
ckit expression is upregulated by Th2/Th17 inducing 
stimuli and ckit induced PI3K-Akt pathway mounts IL-6 
production [4]. Mice devoid of SCF or CD117 are deficient 
in mast cells (W, Sl) and have further abnormalities. If 
completely devoid of ckit receptor, mice die within 10 
days after birth for severe macrocytic anemia, ckit hence 
is indispensable for survival and development, it is a 
prerequisite for the development of myeloid cells. In utero 
transplantation of wild type, fetal liver rescues mice and 
enables research application. To overcome the lack of 
exclusivity, diphtheria toxin-, and cre- inducible, more 
mast cell-specific ablation techniques were developed [5].
A multitude of mutations exists within the ckit gene, 
often leading to enhanced or aberrant activation and 
behavior of mast cells. These mutations are clinically 
difficult to pinpoint, there is only one mutation clinically 
screenable, the remaining fifty or so already described 
mutations are only possible to identify in research settings. 
Mast cell activation syndrome is a recognized entity, due 
to the usually concomitant presence of several ckit gene 
mutations in the same individual. The diagnosis of the 
syndrome is cumbersome for the transient nature and vast 
variability in the clinical and laboratory presentations [6]. 
Mutations in stem cell factor may lead to leukemia, small 
cell lung cancer, gastrointestinal- and germline tumors. 
As mice and humans age, mast cells increase in 
numbers, beyond that strain specificity is present, BALB/
c mice are more abundant in mast cells than C57BL6 /
J mice, females have more mast cells than males, and 
chronic allergic conditions are associated with increased 
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mast cell numbers.
Recently, white adipose tissue (WAT) is becoming 
appreciated as an important source of mast cells and 
precursors, that are committed to the mast cell lineage, 
home to peripheral tissues. Adipose tissue-derived colony-
forming cells when cultured with IL-3 and SCF, gradually 
acquire mast cell phenotype, and more than 40% express 
tryptase, can differentiate into both mast cells types and 
very efficiently colonize the periphery, but they do not home 
to hematopoietic tissues [7]. In the WAT of lean subjects 
without inflammatory activity, mast cells represent a minute 
proportion, but their numbers and tryptase activity [8] 
increase in metabolic syndrome and obesity, characterized 
by low-level inflammation [9]. Mast cells regulate adipocyte 
adaptation to cold in the white adipose tissue [10].
There is an abundance of signaling receptors present 
on mast cells [11]: FcεRI, FcεRII/low affinity (CD23), Fcγ 
receptors, pattern recognition receptors(PRRs, TLRs), 
complement receptors C3aR, C5aR [12], purinergic 
P2X4, prostanoid PR3 [13], etc, hormone receptors. MC 
activation upon IgE crosslinking is the prototypic MC 
response to allergens, but MCs are multifaced cells with a 
multitude of immune functions. The variety of recognition 
receptors enables mast cells to react to environmental, 
exogenous, and endogenous triggers, as primary effectors 
or adjuvants, aggravating immune response, deriving 
towards a Th1, Th17, or Th2 phenotype, presenting 
processed antigens in an inflammatory environment, 
unfolding cryptic epitopes, enhancing inflammatory cell 
death, serving as viral reservoirs, modulating cytokines, 
and impelling the extent of the immune response.
While a significant redundancy may be present in 
receptor utilization and immune functions in innate 
microbial defense, MCs may become prevalent in an 
aberrant immune environment, such as irradiation for 
example into which mast cells in comparison to other 
immune cell types are relatively more resistant [14]. Mast 
cells respond to various types of stimuli with differential 
degranulations, or chemokine, cytokine production. Anti-
IgE or IgG cross-linking produces a slower, progressive, 
and sustained degranulatory response, while activation 
of MCs via substance P (SP), C3a, C5a, produces 
a fast, expulsive response. Differences exist also in 
intracellular degranulatory signaling pathways in the 
context of stimulus [15]. The direction and extent of the 
immune response are based on the complexion of the 
exogenous or endogenous danger signals, the engaged 
recognition receptors with their signaling pathways, and 
the underlying cytokine milieu. TLRs, particularly TLR4 
function in this manner proximally, including mast cells, 
setting the stage for an overall immune response [16]. Mast 
cells can be activated by cytokines. IL-33, released from 
barrier cells: keratinocytes, endothelial and epithelial 
cells, fibroblasts in response to damage and inflammation 
is a potent mast cell activator. IL-4, the major Th2 and 
allergy-related cytokine serves as a selective modifier 
of mast cell action deriving towards Th-2 related 
cytokine response (IL-4,5,13) and downregulation of 
proinflammatory IL-6 and TNFα production in response 
to IgE mediated reactions and gram-negative bacterial 
activation. Follicular T cell-produced IL-4 is required to 
generate and sustain IgE production [17].
3. MC Secretory Products
The variety of mast cell secretory products is 
overwhelming, a few examples are highlighted here. 
As opposed to pancreatic proteases, MC proteases are 
released from the cell in active form. Proteases are 
constitutive and distinct components of mast cells, with 
low levels present in basophils and macrophages, too. 
MC subpopulation signature chymase, a peptidolytic 
serine protease has a wide assortment of targets: 
fibronectin, procollagenase, high mobility group box 1 
(HMGB1), tight junction proteins, thrombin, angiotensin 
I, substance P, IL-1β, IL-6, IL-13, TNFα, etc. [18]. Human 
MC chymase can degrade alarmins (HMGB1), degrade 
the virulence factor of Trichinella spiralis, cleave 
influenza hemagglutinin to increase virulence [19,20]. A 
male predominance is known in acute coronary events 
and dilated cardiomyopathy, and interestingly estrogen 
can inhibit MC chymase release and prevent pressure 
overload-induced adverse cardiac remodeling [21]. The 
chymase effect can be thereupon detrimental or beneficial, 
depending on the context. 
MC tryptase, another serine protease has the potential 
to induce extracellular matrix proliferation, by stimulating 
fibroblast migration factor release [22]. MC tryptase 
contributes to the pervasive macrophage population 
of chronic obstructive pulmonary disease (COPD) 
lungs and dynamizes their pro-inflammatory cytokine 
expression (IL-1β, TNFα) [23]. During chronically ongoing 
inflammation, in COPD for example, mast cells contribute 
to the development of fibrosis via TgFβ induction. An 
important excretory product of mast cells is granzyme D 
(GD), a serine protease produced by NK and CD8 cells, 
likewise. GD released upon stimuli from gram-positive or 
gram-negative bacteria, or IgE cross-linking enters target 
cells via perforins and induces apoptosis per caspase-
dependent and independent pathways, activation of 
reactive oxygen species (ROS) production. GD expression 
is decreased in TLR2 KO mice, pointing towards TLR 
signaling pathway involvement at GD production [24].
DOI: https://doi.org/10.30564/jim.v10i2.4111
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Histamine generated and released from mast cell 
granules serves physiological roles by regulating the 
sleep and wakefulness cycle, inducing vasodilation, 
vasopermeability, smooth muscle contraction, and 
mucus production. Histamine has a profound effect on 
monocyte and T lymphocyte phenotypes. Myeloid-derived 
suppressor cells (MDSCs), harboring the histamine 
(HR1-3) receptors are conditioned by mast cells, in their 
presence both granulocytic and monocytic monocytes 
increase in numbers and histamine promotes their survival 
and proliferation in culture, and coculture of monocytes 
and histamine enhances IL-10 and decreases Th1 related 
IL-12 production. Allergic patients have higher MDSCs 
in comparison to healthy control [25]. MDSCs, mast cells, 
and regulatory T cells assemble in an immune-suppressive 
network, that promotes tumor growth [26]. Mast cells 
histamine can upregulate TLR2 and TLR4 expression.
4. Mast Cells and Endocrine Disruptors
Behavioral neuroscience is deeply engaged in 
understanding the regulation of social and sexual 
behavior. The important function of mast cells, sexual/
gonadal development during intrauterine and postnatal 
life comes to scrutiny when realizing how deeply they can 
be affected via minute dysbalances in hormonal levels, 
and how decisive an impact the environment may have on 
human health and reproduction. 
In many aspects of immunity, sexual hormones have 
important functions and the reversed question, how 
immunity affects sexuality, has been asked less frequently. 
Brain mast cells are strategical mediators of brain sexual 
differentiation. Male mice have more mast cells and 
dendritic cell synapses in the preoptic area (POA), the 
main center of sexual behavior. When newborn female 
mice were exposed to either testosterone or its active 
metabolite estradiol, phenotypic switching took place by 
mast cell proliferation and engagement. Dendritic cell 
spine proliferation in POA was increased via the estradiol- 
mast cell-histamine-microglial axis [27].
Epigenetic modification has been suggested to have 
the capability to modify sexual orientation. According to 
Lenz et al, for example, prenatal exposure to allergens 
may contribute to adulthood social and sexual behavioral 
changes via disrupting sexual differentiation. Adult female 
mice, exposed to an allergen during prenatal development 
demonstrated male patterns of mounting behavior, 
while male mice had decreased copulatory behavior and 
decreased olfactory preference towards females. Prenatal 
indirect exposure of mice to microbial TLR ligands via 
maternal infection, has led to behavioral "difficulties" and 
it appears that mast cells may be responsible for the effect 
of sex hormones on the developing brain [28].
Mast cells harbor on their surface the estrogen receptors 
(ER), progesterone receptors (PR), and testosterone 
receptors. Beyond the influence on sexual differentiation, 
EDCs -for example, phthalates and parabens- can interfere 
with prostaglandin (PG) synthesis in Sertoli cells and mast 
cells. PG is inhibited via EDC binding to the active site of 
the cyclooxygenase (COX) enzyme [29]. Sertoli cells fulfill 
important functions during spermatogenesis. The PG 
pathway is important in the masculinization of the male 
reproductive tract during prenatal development. 
Endocrine disruptors (EDCs) are environmental 
chemicals that interrupt or modify various natural 
hormonal pathways, they modulate biotransforming 
enzyme activities, ion channels, occupy plasma protein 
transporters, induce mast cell degranulation, etc [30]. 
EDCs are a diverse entity of chemicals used in food 
processing, cosmetics, toys, drinking containers, plastic 
containers, water pipes, laundry detergents, herbicides, 
pesticides, etc. Among important disruptors are phthalates, 
benzophenones, parabens, estradiol, bisphenols, dioxins, 
etc. EDCs interface with many hormonal receptors, 
such as estrogen receptors, progesterone receptors, aryl 
hydrocarbon receptors (AhR), adrenal, and thyroid 
receptors. EDCs influence signaling pathways through 
the engagement of the above receptors variably, 
in a competitive manner. Their dose-effect may be 
proliferative, suppressive, mutagenic, they can inhibit, 
activate, modulate enzymatic activities, they can have 
binary dose effect, delayed effect, epigenetic effect 
through DNA, and histone methylation, importantly their 
effect is often cumulative. EDCs may be soluble in water 
or often in lipids, may have metabolically active and toxic 
degradations products, and due to often long half-lives 
their amount may sore up in the adipose tissue or organs, 
and with a depo effect, they may continuously assault the 
human body to the point beyond repair. The brain is a 
lipid-rich tissue and prenatal to toddler exposure may be 
relatively higher than in adults [31]. Around 62000 different 
chemicals are in use currently, in which the Environmental 
Protection Agency could not produce evidence in their 
separate, singular toxicity to the environment or humans. 
There are many attempts to regulate the use of EDCs. To 
be considered EDC, the producing company or scientific 
literature must present data regarding adverse health 
effects. Certain chemicals have proven harmful to humans 
and animals. But while many chemicals introduced into 
the environment, particularly with the speedy technical, 
biochemical, and agricultural development of the past 20th 
century comply individually with the "safety dose limits", 
the potential cumulative effect on the limited number of 
DOI: https://doi.org/10.30564/jim.v10i2.4111
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human and animal hormonal receptors represents a real, 
underrated danger. The disputes over the potential toxicity 
of already prefaced chemicals are lengthy, the causative 
relationship between the environmental chemical and 
disease development providing long term low dose 
exposure is hard to prove, and during the period of legal 
debate and often beyond, contamination is proceeding. 
Among the important endocrine disruptors (EDCs) 
is atrazine, the herbicide used in eliminating broadleaf 
weeds in crops, particularly corn. The triazine type chem-
ical, soluble in water, has a long half-life, including me-
tabolites. When 14C isotope of atrazine was administered 
to the soil for three consecutive years, follow-up studies 
demonstrated the presence of the radioactive substance in 
83% of original levels 9 years later, and 25% still present 
22 years later [32]. Due to the slow biodegradation, atrazine 
currently represents one of the major water pollutants 
despite the fact, that in 2004 it has already been officially 
banned in the European Union. Atrazine introduction to 
the environment from the 1950s has had faster dynamics 
than its biodegradation, creating a cumulative effect on 
its own. In several animal species, atrazine has been 
shown to interfere with gonadal development and thyroid 
function, slow porcine oocyte maturation, disrupt DNA 
integrity, and cause the death of oocytes [33]. Atrazine's 
influence is complex, it decreases sperm count, delays 
puberty and has obesogenic effect [34]. Atrazine in vitro 
induces degranulation of rat thyroid mast cells and in the 
RBL2H3 basophil cell line [35].
Alkylphenols,  used as surfactants in washing 
detergents, are poorly water-soluble, may cumulate in 
adipose tissue, bind to ER receptors, and stimulate mast 
cell degranulation in a FcεR dependent and independent 
way, they also promote Th2 polarization [36].
Aryl hydrocarbon receptor (AhR) is one of the most 
important environmental gatekeepers in the human 
body. AhR is an intracellular transcription factor, that 
in communication with multiple signaling pathways 
influences proliferation, apoptosis, energy metabolism, 
and cholesterol synthesis, immune cell development, and 
function, serves constitutively in an antiinflammatory 
position, cell migration, hormonal pathways, and 
stimulates the xenobiotic detoxifying CYP genes [37,38]. 
The receptor is ancient in its origin, dates more than five 
hundred million years back, and is essential for existence, 
as AhR deficient mice die a few weeks after birth. AhR 
has several exogenous and endogenous ligands, such as 
dioxin, polycyclic aromatic hydrocarbons (PAH), and 
from endogenous ligands tryptophan metabolites, like 
kynurenic acid and tryptophan metabolic products of 
microflora activate AhR. The exogenous ligands come 
from tobacco smoke, diesel exhaust, indoor heating, 
electronics, construction material, plastics, inner coating of 
water pipes, and food containers. AhR is present in many 
cell types in the body including mast cells, epithelial cells, 
etc, highly expressed in the liver, lungs, etc. Because AhR 
possesses important biological homeostatic functions, 
the inappropriate and overt engagement, disabling the 
physiological function of the receptor, overwhelming 
biotransformation capacity, may lead to organ and 
immune dysfunction. There is variability in the character 
of AhR response to different ligands depending on the 
dose or timing, they may promote Th17 or Treg phenotype 
[39]. Dioxin undergoes slow degradation of seven to ten 
years, impersonating a particular danger skewing the 
immune response towards overt proinflammatory or 
immunosuppressed phenotype. Accidentally, the effect 
of xenobiotics may become protective, in the case of 
estrogen-dependent breast cancer AhR decreases estrogen 
receptor activity, or coal tar in skin psoriasis improves 
skin barrier function, occupationally may however cause 
skin cancer [40]. Polycyclic aromatic hydrocarbons (PAH) 
represent environmentally frequent AhR ligands, some 
with cancerogenic potential, upon binding to AhR and 
via alternative routes. They are present in the ambient 
air, arising upon combustion, unburned hydrocarbons in 
automobile exhaust, resuspended road dust, coal burning, 
metal manufacturing, tobacco smoke, etc. AhR enhanced 
CYP1B1 activity is correlated with poor outcomes in 
glioblastoma patients. The adverse effects may be related 
to overt reactive oxygen species (ROS) production and 
DNA damage, proliferation, loss of differentiation [41]. 
AhR is abundantly expressed in mast cells, colocalizes 
with tryptase, and is upregulated in endometriosis patients 
on lesion-specific mast cells [42]. Mouse bone marrow-
derived MCs(BMMCs) constitutively express the AhR 
receptor and upon stimulation with FICZ (endogenous 
tryptophan ligand) show CYP1A1 and CYP1B1 activation 
and enhanced ROS production [43]. Bisphenol A and 
estradiol stimulated BMMCs in vitro showed enhanced 
histamine release. Perinatal Bisphenol A exposure induced 
decreased DNA methylation in adult mice [44]. Mast cells 
and AhR are antiquated motifs, essential bricks in living 
organisms from very early and primitive forms, to highly 
complex mammals. Toxic exogenous insults therefore 
may have far-reaching consequences for many lifeforms 
on Earth.
5. MC Hormonal Interactions
Mast cells contribute in alliance with stress hormones to acute 
and chronic stress responses. Genetic mapping demonstrated 
over eight thousand genes differentially expressed among 
DOI: https://doi.org/10.30564/jim.v10i2.4111
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female and male mouse mast cells in response to immunological 
and psychological stress. IgE mediated allergic response induced 
a more aggravated and speedy response in female mast cells, 
in terms of tryptase, histamine serum levels and BMMCs from 
female mice had increased TNFα, histamine, β-hexosaminidase, 
and tryptase release. Among the upregulated genes, differential 
expressions were observed in TNFα, mast cell protease 1,2,4,8, 
tryptase, cathepsins, and several genes involved in granule 
biogenesis and maturation underscoring the relevance of sex 
differences in mast cell-mediated immune responses [45].
Acute stressors, by the means of corticotropin-releasing 
hormone (CRH), excreted from the paraventricular 
nucleus of the hypothalamus, activate the hypothalamic-
pituitary-adrenal axis of the flight or fight reaction. 
CRH receptors are present on the surface of mast 
cells, CRH itself is secreted by mast cells, inducing an 
inflammatory response, degranulation exocytosis with 
a massive 5-hydroxytryptamine release [46]. Perceived 
stress is a major trigger for CRH release in the periphery, 
for example, skin sensory neurons and mast cells, 
nasal mucosa, react with CRH-R1 mediated mast cell 
degranulation [47]. Stress-induced increase in serum CRH 
levels, for example, if ignited by acute restraint, leads to 
brain, skin, lung MC degranulation and worsens blood-
brain barrier tightness, neuroinflammation, and acute 
asthma attacks [48]. Patients with psoriasis and atopic 
dermatitis too, have increased serum CRH levels and their 
symptoms can be aggravated by psychological stress. 
CRH is implicated in gut hypersensitivity in irritable 
bowel syndrome (IBS) and inflammatory bowel disease 
[49]. Ex vivo exposure of porcine intestinal cells to CRF 
showed increased mast cell degranulation, tryptase, and 
TNFα release, and gut permeability due to disruption 
of tight junctions, these effects were prevented with 
cromolyn pretreatment [50]. Mice exposed to 60 or 120 
minutes of restraint stress produced high levels of serum 
IL-6, increased vascular permeability measured by 99Tc 
extravasation, and skin CRH content. These changes were 
remarkably diminished in MC deficient mice [51].
The interaction of mast cells with the hormonal milieu 
shapes the immune response. Mast cells have been 
shown to interact with virtually all hormonal systems, 
the sex, stress hormones, the thyroid, adrenal gland. 
The predominant hydroxyreductase in mast cells is 11 
beta- hydroxyreductase (11βHSD1). The function of 
this enzyme is to convert cortisone in target cells to 
cortisol, produced mostly, but not exclusively in the liver, 
contributing to obesity, diabetes. 11βHSD1 is upregulated 
in the sites of inflammation, in mast cells, in macrophages, 
etc. In mast cells, they lead to decreased degranulation [52].
The interaction of mast cells and aldosterone was 
demonstrated using mast cell knockout mice. Aldosterone, 
one of the main regulators of fluid, sodium, and potassium 
homeostasis is produced by the cells of zona glomerulosa 
of the adrenal cortex in response to low potassium levels, 
in order to stimulate by the renin-angiotensin system. 
Subcapsularly located adrenal mast cells via serotonin 
production stimulate aldosterone synthesis and release 
from the adrenal gland. Low sodium levels triggered mast 
cell tryptase synthesis and aldosterone production in aged 
female BALB/c mice [53]. While deficiency of mast cells 
is rare, the question remains how inadvertent adrenal 
mast cell activation, for example during sepsis, influences 
electrolyte and fluid balance.
Thyroid hormones and metabolites are present in 
mast cells, and the thyroid receptors are present on their 
surface, consequently the MC – thyroid interaction is 
bidirectional. Antithyroid peroxidase (TPO) antibodies 
present in autoimmune thyroiditis can directly activate 
and degranulate mast cells, while during Graves 
ophthalmopathy mast cells  in elevated numbers 
contribute to orbital fibroproliferation. The number and 
the distribution of mast cells are influenced by thyroid 
hormones in many organs. Mast cells interact with 
chondrocytes and osteoblasts and contribute to the T3 
actions on bone remodeling and chondrocyte growth [54]. 
Non-thyroidal illness (NTI) or euthyroid sick syndrome 
is characterized by low T3 and or T4 without increased 
feedback thyroid-stimulating hormone (TSH) levels. 
Among clinical intensivists, the role of peripheral thyroid 
silence is debated, whether it is a maladaptive change 
rather than recuperation of resources during bacterial 
infection and sepsis. NTI is a rather frequent finding 
during prolonged sepsis and low T3 levels represent an 
independent negative predictor for sepsis mortality. The 
notion, that bacterial lipopolysaccharide (LPS) causes 
peripheral suppression of thyroid hormones via MyD88 
signaling and mast cells skews the dialogue towards the 
maladaptive hypothesis. Mice deficient in MyD88 did not 
develop a hypothyroid response. The thyroid dysfunction 
in inflammation is also due to LPS induced hypothalamic 
dysfunction and can be reversed with thyrotropin-
releasing hormone (TRH) administration [55]. There is 
no consensus as per thyroid substitution in sepsis, and 
there are experimental indications that intravenous T3 
administration may have beneficial relevance [56].
6. MC in Viral and Bacterial Infections
MCs contribute to immune response fronting primarily 
helminth, but also viral and bacterial infections. Mast cells 
are a reservoir for HIV. FcεR crosslinking on the surface 
of mast cells leads to enhancement of CXCR4 homing 
DOI: https://doi.org/10.30564/jim.v10i2.4111
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receptor expression and increased HIV viral tropism [57]. 
During hepatitis B and C infection, the Fv sialoprotein 
is produced in large amounts from the liver, binds to the 
heavy chain of the main immunoglobulin subfamilies, 
including IgE and leads to mast cell and basophil 
degranulation, histamine, and tryptase release from lung 
and skin mast cells [58].
Mast cells have been shown to participate and 
degranulate upon bovine respiratory syncytial virus (RSV) 
infection. Involvement of virus-specific IgE and RSV 
infection predisposes to the future development of asthma 
and allergy. RSV upon nasal inoculation to guinea pigs 
persisted for up to 60 days [59].
MC enhances the virolytic ability of CD8 virus-
specific cells in lymphocytic choriomeningitis virus 
(LCMV) infection, thus controlling the infection, but their 
function in asthmatic and COPD patients may become 
ambivalent due to a concomitant increase in airway 
reactivity [60]. Postmortem analysis of alveolar mast cells 
of COVID-19 patients shows increased density, enhanced 
IL-4 production by alveolar macrophages and type II 
pneumocytes in comparison to control or H1N1 infected 
lungs [61]. Significantly elevated serum levels of chymase, 
tryptase, CPA3 (mast cell carboxypeptidase A) were found 
in COVID-19 patients when compared to healthy volunteers. 
Another study showed significantly elevated CPA3 serum 
levels in severe COVID disease [62]. Mast cells may have 
a protective role in microbial clearance, and detrimental 
function in aggravating airway hyperresponsiveness and 
fibrosis.
7. Mast Cells, Allergies, and Asthma
Mast cells and basophils are essential components 
of type I immediate hypersensitivity reactions. The 
prototypic anaphylactic response is triggered by 
crosslinked IgE in previously sensitized individuals and 
mediated by histamine, tryptase, platelet-activating factor 
(PAF), etc [63]. IgE crosslinking leads to abrupt activation 
of signaling pathways: IgE binds to high-affinity FcεRI on 
the surface of mast cells. There are approximately 3x10*5 
FcεRs on the surface of mast cells and a 0,3% or antigen-
specific IgE receptor occupancy is needed for mast 
cell activation, and importantly certain mono-antigenic 
IgEs render polyreactivity. Several viral, bacterial, 
helminth superallergen proteins possess the capacity to 
crosslink IgE and contribute to an aggravated mast cell 
sensitivity [64]. Fine particular matter of the ambient air 
has been shown to crosslink FcεR and worsen asthma 
symptoms in susceptible patients. Upon IgE engagement, 
prestored mediators are rapidly released via degranulation 
(histamine, heparin, proteases, TNFα), later de novo 
synthesized prostaglandins, leukotrienes, cytokines follow. 
A predominantly Th2 immune environment enhances the 
allergic phenotype. Th2 associated cytokines IL-4 and IL-
13 promote IgG and IgM antibody switch to IgE subtype, 
and pattern recognition receptor (PRR) activation may 
serve a synergistic function. Human DCs harbor histamine 
receptors and histamine modulates the cytokine profile 
of DCs by downregulating IL-12 and stimulating IL-
10 production to skew T cells toward an IL-4 producing 
phenotype [65].  As to why certain individuals are 
susceptible to allergens, remains to be fully understood, 
the number of allergic and asthmatic individuals in recent 
decades however is growing. House dust mite (HDM) 
induced allergies, female sex, airway hyperresponsiveness 
in childhood are all independent predictors of adulthood 
asthma persistence. Importantly, anaphylactoid or pseudo- 
allergic reactions can occur without previous sensitization 
independent of IgE crosslinking, via activation of Mas-
Related G-protein coupled receptor-X2 (MRGPRX2) on 
the surface of connective tissue mast cells, inducing a 
more transient and speedy degranulation, with dominant 
tryptase contribution. Drug-induced anaphylactoid 
reactions represent a sizeable group of potentially 
severe adverse medication effects, particularly in 
intravenously applied cationic small molecules. Among 
the most widely used medications are nondepolarizing 
nonsteroidal muscle relaxants and opioids used in general 
anesthesia and intensive care, fluoroquinolone antibiotics, 
vancomycin, antidepressants [66,67]. Endogenous mediators 
like substance P(SP) can lead to MC degranulation via 
MRGPRX2 receptor, mediating pain and itching. Further, 
somatostatin, defensins can act via binding to MRGPRX2. 
There are 30 single nucleotide polymorphisms (SNP) 
described in the receptor structure, rendering some 
individuals more, others less reactive to receptor agonists.
Protease allergens (PA) represent a particularly 
dangerous group of allergens because they possess 
multiple immunomodulatory properties and trypsin, 
cysteine, chymotrypsin-like protease activities. Protease 
allergens are particularly abundant in house dust mites, 
moreover, cockroaches, certain fungal allergens, and 
staphylococcal proteins possess protease activity [68]. 
HDM PAs are dispersed upon fecal contamination of fine 
particular matter (FPM). In susceptible individuals, PAs 
activate MCs employing crosslinking IgE, via SP release 
and MRGPRX2 engagement, and a dominant PA, Depr2 
mimics the MD-2 molecule of the TLR signaling complex, 
promoting inflammation via adjuvant effect. According to 
studies, HDM is present in 70% of the central European 
households, and 50% of allergic patients are sensitized to 
dust mites. The effect of inhalational PA on the immune 
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system of the host is surprisingly manyfold. Derp1, 
with cysteine-like protease activity, can disrupt the tight 
junctions between airway epithelial cells, can destroy 
IL-2 receptors, required for Th1 and Treg proliferation, 
further skewing T cells towards Th2 phenotype. The lung-
protective surfactant A can bind allergens, Depr1 however 
overcomes this obstacle by cleaving the surfactant protein. 
CD23, the low-affinity IgE receptor on the surface of B 
cells, negatively regulates IgE levels but is cleaved too 
by Derp1. A similar immunomodulatory effect has been 
shown experimentally for Per a 10, a major cockroach 
allergen [69]. Fine particular matter, defined by size below 
2,5mm associated with air pollution in urbanized areas, 
is of preponderant interest for its small size and ability 
to reach small airways, alveoli. Inhalation of the fine 
particular matter is associated with acute agitation of 
asthma symptoms, particularly in children with allergic 
asthma. In vitro experiments confirm reactivity of bone 
marrow-derived mast cells, particularly to higher doses 
of FPM in terms of apoptosis, enhanced IgE mediated 
degranulation [70], increased IL-6, TNFα, and MCP-1 
secretion. 
8. Mast Cells and the Heart
The human heart accommodates mast cells in vascular 
intima, perivascularly, and interstitially. The involvement 
of mast cells and immune-mediated processes is 
compelling in acute and permanent atrial fibrillation, 
heart failure, myocardial ischemia, atherosclerotic plaque 
development, and rupture. 
Cardiomyocytes are not capable of proliferation and 
nonphysiological stress leads to their hypertrophy and/ 
or degeneration. The renin-angiotensin-aldosterone 
system (RAS) is a driving force behind hypertensive 
cardiomyopathy and human mast cells are involved due 
to renin production and angiotensin-II generation from 
angiotensin-I by chymase, behaving in a convertase 
manner [71]. The profibrotic potential of RAS has been 
demonstrated, and angiotensin-converting enzyme 
inhibitors carry the potential of reducing cardiac 
remodeling. The signature profibrotic cytokine is TgFβ, 
and mast cell degranulation leads to the activation of 
profibrotic signature, myofibroblast generation, and 
collagen deposition [72]. Pressure overload due to increased 
peripheral vascular resistance leads to infiltration and 
proliferation of cardiac mast cells, with interstitial 
fibrosis and increased sensibility towards ectopic atrial 
pacing, irregular ectopic atrial activity- atrial fibrillation 
by creating aberrant pathways for cardiac conduction. 
Both pathognomic features are abrogated upon mast cell 
stabilization with cromolyn and in MC knockout (KO) 
mice [73]. Repeated paroxysms of atrial fibrillation may 
conclude in permanent atrial fibrillation, signatures of 
acute versus chronic inflammation and degeneration, 
mast cell degranulation versus fibrosis. Histamine 
release from cardiac mast cells may trigger coronary 
spasm in predisposed patients. Experimentally, injection 
of histamine caused spasm in cadaveric coronaries [74]. 
Due to the strategical location of MCs in and around 
coronary vessels, their contribution to atherosclerotic 
changes is of interest. Beyond obesity, diabetes, and 
dyslipidemia, acute and chronic stress represents 
contributors to the development of the acute coronary 
syndrome. When apolipoprotein E (apoE) KO mice on 
Western diet were subjected to 120 minutes of restraint 
stress, significant activation of mast cells in the heart was 
observed, altogether with increased corticosterone and 
IL-6 levels, a shift towards neutrophils, with large size 
intraplaque hemorrhages, these changes were abrogated 
in MC KO mice. Increased numbers of mast cells were 
observed in the areas of atherosclerotic lesions, with the 
highest numbers and greatest level of degranulation in 
the areas of ruptures, and the intimal thickness showed 
a correlation with chymase activity. MC chymase can 
promote apoptosis of smooth muscle cells by degrading 
fibronectin, by disrupting focal adhesion complexes and 
Akt dephosphorylation, events that are needed for cell 
survival and adhesion. Chymase blocks NF-κB mediated 
survival of smooth muscle cells, NF-κB´s translocation 
to the nucleus is abolished and Bcl2 mRNA levels 
are decreased, leading to mitochondrial swelling and 
cytochrome c release [75]. Mast cells have been shown 
to promote lipid accumulation and foam formation. 
Instances of acute myocardial ischemia associated with 
severe anaphylactic reactions, the Kounis syndrome, are 
documented in the literature [76]. These reports indicate 
mast cell-mediated coronary plaque rupture upon allergic 
reactions to known pharmacological and environmental 
allergens, such as myorelaxants, aspirin, acetaminophen, 
antibiotics, gadolinium, food. Three types of Kounis 
syndrome have been described, type I in non-stenotic 
coronaries, when inflammatory mediator release leads 
to coronary vasospasm and myocardial ischemia, type 
II in silent atheromatous coronaries when spasm may 
lead to ischemia or/and ultimately to coronary plaque 
rupture, finally type III representing stented patients with 
thrombosis or stent restenosis due to xenobiotic induced 
anaphylactic or anaphylactoid reaction. As mentioned 
earlier, mast cell degranulation may be prompted via 
complement component C5a, a potent anaphylatoxin 
arising upon C5 cleavage by alternative, mannose-
binding lectin or classical complement pathway serine 
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protease - C5 convertase activation, and binding upon 
CD88 receptor on the surface of mast cells, macrophages. 
C5a is a potent chemoattractant, causes smooth muscle 
contraction and increases vascular permeability, and can 
trigger mast cell degranulation. ApoE deficient mice, 
prone to severe atherosclerosis have been treated with 
C5a. Plaque disruptions increased from 13% to 56%, and 
the length of ruptured plaque was increased likewise, but 
cromolyn treatment could not reverse C5a effects. C5a 
induced apoptosis via the caspase apoptotic pathway, and 
while caspase-1 and TNFα expressions were unchanged, 
caspase-3 levels were increased and TUNEL assay 
revealed doubling of apoptotic cells from 2.4% to 5.9% 
of total cell number upon C5a treatment [77]. Mast cells are 
implicated in Coxsackie B3 virus-induced experimental 
myocarditis, where signature proximal positive and 
negative regulators of heart passaged virus-induced 
inflammation on mast cells and macrophages- TLR4 
and TIM3- set the inflammatory events to a degree and 
direction that is influenced by sex [78].
9. Mast Cells and the Brain
The pathophysiology of neurodegeneration is complex. 
Neuroinflammation, autoimmunity, and inflammatory 
cell death are common features of Alzheimer's disease, 
Parkinson's disease, and dementia. As per Parkinson's 
disease, a form of chronic neurodegeneration, the alpha-
synuclein misfolded protein accumulates in dopaminergic 
neurons of the substantia nigra, Lewy bodies are formed 
and neurodegeneration materializes [83]. Among important 
environmental triggers paraquat(herbicide), and rotenone 
(pesticide) are emphasized. These substances interfere with 
the mitochondrial electron transport system, ultimately 
by producing reactive oxygen species leading to the death 
of dopaminergic neurons in substantia nigra. There is a 
locally disrupted blood-brain barrier and soon autoreactive 
activated, mostly Th17 producing T cells populate the region 
aggravating neuroinflammation. The herbicide paraquat 
shows a clear association between inhalational, dermal, or 
oral exposure and the development of Parkinson's disease 
(PD) [84]. Paraquat is an enhancer of reactive oxygen species 
(ROS) formation and in its pure form leads to severe acute 
respiratory distress syndrome (ARDS). MCs treated with 
MPP+(experimental neurotoxin) showed degranulation 
and MMCP6,7 (corresponding to human tryptase) release, 
moreover, co-culture of BMMCs with neurons aggravated 
this response. Mast cells are located adjacent to microglia, 
and upon stimulation, a persistent glial activation emanates. 
MMCP6 and 7 lead to CCL2 release from astrocytes and 
glial cells activation, neurodegeneration measured by 
neurite outgrowth [85]. In the brain lesions of Alzheimer's 
and, Parkinson's patients autoimmune T cells and Foxp+ 
regulatory T cells are present likewise. The emergence of 
autoimmune conditions is manyfold, and under preexisting 
inflammatory conditions presentation of previously 
unseen cryptic epitopes may occur, leading potentially 
to autoimmunity. Likewise, the presence of ROS further 
aggravates the apoptotic process, creating a multimodal 
self-perpetuating pathological circuit of death and 
autoinflammation. The involvement of antigen processing 
and presentation appears to be necessary for PD to develop, 
this has been demonstrated on major histocompatibility 
complex(MHC)II KO mice, in whom MPTP (a prodrug to 
MPP+) intoxication did not lead to cell death, nor release 
of pro-inflammatory cytokines. Even when α-synuclein is 
overexpressed, but MHCII is not present, mice are protected 
from microglial activation, and neuronal cell death [86].
Concerning acute traumatic and inflammatory 
conditions, intracerebral bleeding, and ischemia, beyond 
augmenting inflammation in the central nervous system, 
mast cells also contribute to the increased permeability of 
the blood-brain barrier (BBB), enabling toxins previously 
precluded from entering the brain to centralize [87]. MCs 
are located in the pia mater, brain parenchyma, and 
vessels, facing the brain. Experimental stabilization with 
cromoglycate, similar to mast cell deficiency, led to a 
50-60% decrease in brain swelling and BBB leakage. 
Considering our limited resources in the management 
of brain swelling using traditional methods, these data 
must be taken seriously. Histamine by its virtue increases 
edema formation in general, together with circulating 
platelet aggregating factor (PAF) from neutrophils and 
monocytes, upon enhancing nitric oxide (NO) production, 
and by VE-cadherin rearrangement in endothelia [88]. 
In the mouse model of focal cerebral ischemia, lack of 
MCs in C57BL6/J mice, similarly to intraventricular MC 
stabilization using cromoglycate, significantly decreased 
edema formation upon transient - 45 minute- middle 
cerebral artery occlusion [89]. The study demonstrates the 
contribution of mast cells to increased BBB permeability, 
vasogenic edema, and ischemia-reperfusion injury to 
disease pathology. The effect of mast cells on leukocyte 
infiltration, BBB permeability was present within four 
hours after injury, and sustained for up to 70 hours of 
injury, demonstrating how mast cells are immediate 
mediators, and later followed up by macrophages and 
neutrophils. The delicate response of the brain to trauma 
is demonstrated in experimentally induced midshaft tibial 
fracture under general anesthesia with sevoflurane, in 
C57BL6/J male mice. A significant increase in mast cell 
numbers was present in the hippocampus one day after 
surgery. While the baseline level of proinflammatory 
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TNFα and IL-1β was not different among experimental 
groups, the increased TNFα and IL-1β production 
were decapitated on day one upon intraventricular 
cromoglycate treatment in wild type mice [90]. The role 
of TLR4 signaling in the ischemia-reperfusion injury 
has been previously emphasized, the abrogation of this 
pathway experimentally leads to improved tissue viability 
and organ functionality [91]. 
10. MC Stabilization
Physiologically vitamin D stabilizes mast cells. Thanks to 
the presence of 25-hydroxyvitamin D1-alpha-hydroxylase, 
mast cells can convert vitamin D to its active form, which 
conversely has a negative regulatory role on mast cell 
maturation in the bone marrow. Both vitamin D and mast 
cell deficiencies are linked to allergic disorders, eczema, 
multiple sclerosis, and tumor development. Active vitamin 
D can induce IL-10 production in mast cells and dampen 
IgE mediated mast cell activation, in the presence of the 
functional CYP27B1 hydroxylase, that is constitutively 
expressed in the mast cells. In the presence of active vitamin 
D, percutaneous anaphylaxis is significantly blunted [79]. 
The clinically available mast cell stabilizers are cromolyn 
(disodium cromoglycate) and ketotifen [80]. Cromolyn is a 
preventive mast cell stabilizer, approved for mastocytosis, 
allergic rhinitis, and asthma. It alleviates the extracellular 
calcium influx, preventing the degranulation of mast 
cells. Cromolyn has a good safety profile, but very low 
oral bioavailability and a short half-life [81]. Omalizumab, 
a humanized monoclonal antibody, binding IgE is in 
the introductory stages of application in severe steroid-
resistant asthma and urticaria, indications carefully selected. 
Antihistamines, by blocking the action of histamine by 
binding to H1 or H2 receptors have proven to be instrumental 
in the management of allergy and asthma symptoms. Inhaled 
dexamethasone inhibits mast cell numbers within a few days 
of the administration, smooth muscle reactivity, and restrains 
IgE and IL-33 mediated mast cell reactivity [82]. Ultimately 
adrenaline with potent alpha- and beta-adrenergic activity 
counteracts the profound degranulation-induced disturbances 
in anaphylactic reactions.
11. Conclusions
The delicate balance in homeostasis is disrupted 
during i l lness .  Understanding the pathognomic 
features of the illness, particularly in critical care with 
multiple organ dysfunctions, and treating adequately 
is a true challenge. This review was set to analyze and 
understand the less traditional mast cell aspects, it is a 
glimpse at mast cells in a broader context. Mast cells are 
inevitable or instrumental parts of the immune response 
and homeostasis, but when inappropriately engaged 
or directed, may become detrimental. Current clinical 
options at influencing them therapeutically further, beyond 
allergies and asthma, beyond well-known established 
ways with cromolyn, antihistamines, corticosteroids are 
limited, various shared receptor and pathway modulators 
are clinically tested. Mast cell „stabilization" from an 
evolutionary and inflammatory perspective may come by 
the virtue of indirect measures, by the considerate choice 
of environmental chemicals, particularly during periods 
of heightened developmental sensitivity. An important 
psychosomatic motif can be discovered in the article, 
that the pathological incentives are deeply embedded on 
a molecular level, can be ignited by stress and restraint. 
The epidemics of hypertension can partially be derived 
back to nonphysiological life choices. Mast cells as part 
of overall immune response optimally should clinically be 
monitored. In the complex niché of the immune response, 
that is determined by the etiology of the disease and the 
overall state of the patient due to comorbidities, sex, age, 
race, location. The disease pathology that is time sensitive, 
creates an immune cell and cytokine environment, that is 
to some degree exclusive, individual. Basic cell, mediator, 
survival, apoptosis, and cytokine panels, receptor levels 
would enable us to appreciate the governing forces driving 
and limiting the immediate immune response in time. 
Strategies to influence and direct such responses could 
be developed in an educated manner. Reverberations of 
research incentives in a complex and dynamic system, 
mapping, analyzing, and reacting, are extremely desirable 
attitudes of the future approach to immunological 
challenges.
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